While TAVR is safe for minimally symptomatic patients, questions remain about whether or not it is actually needed. A new analysis in JACC: Cardiovascular Interventions examines this topic in detail.

Novo Nordisk shared initial results from the SELECT trial back in August, but now the full analysis—which includes data from more than 17,000 patients—has been published in The New England Journal of Medicine. 

Ramon Varcoe, MBBS, co-principal investigator for the LIFE-BTK trial, discussed the results with Cardiovascular Business at TCT 2023. "I can't wait to start using these in my patients. It's going to make a huge difference."

Also, Strategic Radiology/RSNA Research Grant goes to Stanford University scientist and local magazine recognizes USRS as one of region's fastest growing companies. 

AI was one of the biggest stories at the American Heart Association’s Scientific Sessions 2023 conference in Philadelphia. Researchers presented new data about heart attack care, voice recognition algorithms, digital stethoscopes and more. 

Monique Rasband, KLAS vice president of strategy and research for imaging, shares the trends she is seeing in the specialty.

“Going forward, patients and medical teams have a choice of two pathways for chest pain relief: chest pain medication or PCI," one cardiologist said. 

“Nearly 300,000 cardiac arrests occur in hospitals in the United States each year, and only about 25% of people survive to hospital discharge after these types of events,” according to one author of a new analysis published in Circulation: Cardiovascular Quality and Outcomes.